G-Protein Coupled Receptors (GPCRs) Market by Product, Assay Type and Application - Global Industry Analysis & Forecast to 2027
Published On : July 2019 Pages : 138 Category: Biotechnology Report Code : HC074411
G-Protein Coupled Receptors (GPCRs) Market by Product (Ligands, Cell Lines, Cell Culture Reagents, Detection Kits) Assay Type (Trafficking Assays, cAMP Functional Assays, Internalization Assays, Calcium Functional Assays, Radioligand Binding & GTPγS Functional Assays, β-Arrestin Functional Assays, Other Assays) Application (Respiratory Research, Cancer Research, Inflammation Research, CNS Research, Cardiovascular Research, Metabolic Research, Other Applications) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The G-Protein Coupled Receptors (GPCRs) Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. GPCRs react to a wide scope of outside upgrade and a section of a few ailment etiologies. Wide utilization of strategies, for example, High-Throughput Screening (HTS), combinatorial science, and therapeutic science, has prompted the recognizable proof of ligands that balance the target's movement.
Drivers and Restraints
Existence of enormous number affirmed medications and medications under clinical and preclinical examinations, which focus on these receptors, support the interest for GPCR screening tests in medication advancement. In addition, an expanding number of allosteric modulators, biological medications, and one-sided agonists that focus on these receptors quicken the interest for related assays.
Regional Insights
Asia-Pacific locale is anticipated to develop at a critical rate during the conjecture time frame, inferable from the monetary advancement of the nations, for example, China and India, alongside expanding government interest in the biotechnology and biopharmaceutical sector.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Becton-Dickinson and Company
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Eurofins Scientific
- Enzo Biochem Inc.
- QIAGEN
- Perkin Elmer Inc.(Cisbio Bioassays)
- WuXi AppTec(HD Biosciences Co. Ltd)
- Abcam plc
- Promega Corporation
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o G-Protein Coupled Receptors (GPCRs) Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Ligands
o Cell Lines
o Cell Culture Reagents
o Detection Kits
o G-Protein Coupled Receptors (GPCRs) Market, By Assay Type, Estimates and Forecast, 2017-2027 ($Million)
o Trafficking Assays
o cAMP Functional Assays
o Internalization Assays
o Calcium Functional Assays
o Radioligand Binding & GTPγS Functional Assays
o β-Arrestin Functional Assays
o Other Assays
o G-Protein Coupled Receptors (GPCRs) Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Respiratory Research
o Cancer Research
o Inflammation Research
o CNS Research
o Cardiovascular Research
o Metabolic Research
o Other Applications
o G-Protein Coupled Receptors (GPCRs) Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Becton-Dickinson and Company
o Thermo Fisher Scientific, Inc.
o Merck KGaA
o Eurofins Scientific
o Enzo Biochem Inc.
o QIAGEN
o Perkin Elmer Inc.(Cisbio Bioassays)
o WuXi AppTec(HD Biosciences Co. Ltd)
o Abcam plc
o Promega Corporation
o G-Protein Coupled Receptors (GPCRs) Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America G-Protein Coupled Receptors (GPCRs) Market, By Country
o U.S. G-Protein Coupled Receptors (GPCRs) Market
o Canada G-Protein Coupled Receptors (GPCRs) Market
o Mexico G-Protein Coupled Receptors (GPCRs) Market
o Europe
§ Europe G-Protein Coupled Receptors (GPCRs) Market, By Country
o Germany G-Protein Coupled Receptors (GPCRs) Market
o UK G-Protein Coupled Receptors (GPCRs) Market
o France G-Protein Coupled Receptors (GPCRs) Market
o Russia G-Protein Coupled Receptors (GPCRs) Market
o Italy G-Protein Coupled Receptors (GPCRs) Market
o Rest of Europe G-Protein Coupled Receptors (GPCRs) Market
o Asia-Pacific
§ Asia-Pacific G-Protein Coupled Receptors (GPCRs) Market, By Country
o China G-Protein Coupled Receptors (GPCRs) Market
o Japan G-Protein Coupled Receptors (GPCRs) Market
o South Korea G-Protein Coupled Receptors (GPCRs) Market
o India G-Protein Coupled Receptors (GPCRs) Market
o Southeast Asia G-Protein Coupled Receptors (GPCRs) Market
o Rest of Asia-Pacific G-Protein Coupled Receptors (GPCRs) Market
o South America
§ South America G-Protein Coupled Receptors (GPCRs) Market, By Country
o Brazil G-Protein Coupled Receptors (GPCRs) Market
o Argentina G-Protein Coupled Receptors (GPCRs) Market
o Columbia G-Protein Coupled Receptors (GPCRs) Market
o Rest of South America G-Protein Coupled Receptors (GPCRs) Market
o Middle East and Africa
§ Middle East and Africa G-Protein Coupled Receptors (GPCRs) Market, By Country
o Saudi Arabia G-Protein Coupled Receptors (GPCRs) Market
o UAE G-Protein Coupled Receptors (GPCRs) Market
o Egypt G-Protein Coupled Receptors (GPCRs) Market
o Nigeria G-Protein Coupled Receptors (GPCRs) Market
o South Africa G-Protein Coupled Receptors (GPCRs) Market
o Rest of MEA G-Protein Coupled Receptors (GPCRs) Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. G-Protein Coupled Receptors (GPCRs) Market, By Product
5.1. Introduction
5.2. Global G-Protein Coupled Receptors (GPCRs) Revenue and Market Share by Product (2017-2027)
5.2.1. Global G-Protein Coupled Receptors (GPCRs) Revenue and Revenue Share by Product (2017-2027)
5.3. Ligands
5.3.1. Global Ligands Revenue and Growth Rate (2017-2027)
5.4. Cell Lines
5.4.1. Global Cell Lines Revenue and Growth Rate (2017-2027)
5.5. Cell Culture Reagents
5.5.1. Global Cell Culture Reagents Revenue and Growth Rate (2017-2027)
5.6. Detection Kits
5.6.1. Global Detection Kits Revenue and Growth Rate (2017-2027)
6. G-Protein Coupled Receptors (GPCRs) Market, By Assay Type
6.1. Introduction
6.2. Global G-Protein Coupled Receptors (GPCRs) Revenue and Market Share by Assay Type (2017-2027)
6.2.1. Global G-Protein Coupled Receptors (GPCRs) Revenue and Revenue Share by Assay Type (2017-2027)
6.3. Trafficking Assays
6.3.1. Global Trafficking Assays Revenue and Growth Rate (2017-2027)
6.4. cAMP Functional Assays
6.4.1. Global cAMP Functional Assays Revenue and Growth Rate (2017-2027)
6.5. Internalization Assays
6.5.1. Global Internalization Assays Revenue and Growth Rate (2017-2027)
6.6. Calcium Functional Assays
6.6.1. Global Calcium Functional Assays Revenue and Growth Rate (2017-2027)
6.7. Radioligand Binding & GTPγS Functional Assays
6.7.1. Global Radioligand Binding & GTPγS Functional Assays Revenue and Growth Rate (2017-2027)
6.8. β-Arrestin Functional Assays
6.8.1. Global β-Arrestin Functional Assays Revenue and Growth Rate (2017-2027)
6.9. Other Assays
6.9.1. Global Other Assays Revenue and Growth Rate (2017-2027)
7. G-Protein Coupled Receptors (GPCRs) Market, By Application
7.1. Introduction
7.2. Global G-Protein Coupled Receptors (GPCRs) Revenue and Market Share by Application (2017-2027)
7.2.1. Global G-Protein Coupled Receptors (GPCRs) Revenue and Revenue Share by Application (2017-2027)
7.3. Respiratory Research
7.3.1. Global Respiratory Research Revenue and Growth Rate (2017-2027)
7.4. Cancer Research
7.4.1. Global Cancer Research Revenue and Growth Rate (2017-2027)
7.5. Inflammation Research
7.5.1. Global Inflammation Research Revenue and Growth Rate (2017-2027)
7.6. CNS Research
7.6.1. Global CNS Research Revenue and Growth Rate (2017-2027)
7.7. Cardiovascular Research
7.7.1. Global Cardiovascular Research Revenue and Growth Rate (2017-2027)
7.8. Metabolic Research
7.8.1. Global Metabolic Research Revenue and Growth Rate (2017-2027)
7.9. Other Applications
7.9.1. Global Other Applications Revenue and Growth Rate (2017-2027)
8. G-Protein Coupled Receptors (GPCRs) Market, By Region
8.1. Introduction
8.2. Global G-Protein Coupled Receptors (GPCRs) Revenue and Market Share by Regions
8.2.1. Global G-Protein Coupled Receptors (GPCRs) Revenue by Regions (2017-2027)
8.3. North America G-Protein Coupled Receptors (GPCRs) by Countries
8.3.1. North America G-Protein Coupled Receptors (GPCRs) Revenue and Growth Rate (2017-2027)
8.3.2. North America G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe G-Protein Coupled Receptors (GPCRs) by Countries
8.4.1. Europe G-Protein Coupled Receptors (GPCRs) Revenue and Growth Rate (2017-2027)
8.4.2. Europe G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific G-Protein Coupled Receptors (GPCRs) by Countries
8.5.1. Asia-Pacific G-Protein Coupled Receptors (GPCRs) Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America G-Protein Coupled Receptors (GPCRs) by Countries
8.6.1. South America G-Protein Coupled Receptors (GPCRs) Revenue and Growth Rate (2017-2027)
8.6.2. South America G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa G-Protein Coupled Receptors (GPCRs) by Countries
8.7.1. Middle East and Africa G-Protein Coupled Receptors (GPCRs) Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Becton-Dickinson and Company
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. Thermo Fisher Scientific, Inc.
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Merck KGaA
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. Eurofins Scientific
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. Enzo Biochem Inc.
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. QIAGEN
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. Perkin Elmer Inc.(Cisbio Bioassays)
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. WuXi AppTec(HD Biosciences Co. Ltd)
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. Abcam plc
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. Promega Corporation
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
10. G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.1. Global G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. G-Protein Coupled Receptors (GPCRs) Market Forecast by Regions (2017-2027)
10.2.1. North America G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.1.1. United States G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.1.2. Canada G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.1.3. Mexico G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.2. Europe G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.2.1. Germany G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.2.2. France G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.2.3. UK G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.2.4. Russia G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.2.5. Italy G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.2.6. Rest of Europe G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.3. Asia-Pacific G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.3.1. China G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.3.2. Japan G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.3.3. Korea G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.3.4. India G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.3.5. Southeast Asia G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.4. South America G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.4.1. Brazil G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.4.2. Argentina G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.4.3. Columbia G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.4.4. Rest of South America G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.5. Middle East and Africa G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.5.3. Egypt G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.5.4. Nigeria G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.5.5. South Africa G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.5.6. Turkey G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa G-Protein Coupled Receptors (GPCRs) Market Forecast (2017-2027)
10.3. G-Protein Coupled Receptors (GPCRs) Market Forecast by Product (2017-2027)
10.3.1. G-Protein Coupled Receptors (GPCRs) Forecast by Product (2017-2027)
10.3.2. G-Protein Coupled Receptors (GPCRs) Market Share Forecast by Product (2017-2027)
10.4. G-Protein Coupled Receptors (GPCRs) Market Forecast by Assay Type (2017-2027)
10.4.1. G-Protein Coupled Receptors (GPCRs) Forecast by Assay Type (2017-2027)
10.4.2. G-Protein Coupled Receptors (GPCRs) Market Share Forecast by Assay Type (2017-2027)
10.5. G-Protein Coupled Receptors (GPCRs) Market Forecast by Application (2017-2027)
10.5.1. G-Protein Coupled Receptors (GPCRs) Forecast by Application (2017-2027)
10.5.2. G-Protein Coupled Receptors (GPCRs) Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure France G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure China G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure India G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) and Growth Rate (2017-2025)
Table Global G-Protein Coupled Receptors (GPCRs) Revenue and Revenue Share by Product (2017-2018)
Figure Global Ligands Revenue and Growth Rate (2017-2018)
Figure Global Cell Lines Revenue and Growth Rate (2017-2018)
Figure Global Cell Culture Reagents Revenue and Growth Rate (2017-2018)
Figure Global Detection Kits Revenue and Growth Rate (2017-2018)
Table Global G-Protein Coupled Receptors (GPCRs) Revenue and Revenue Share by Assay Type (2017-2018)
Figure Global Trafficking Assays Revenue and Growth Rate (2017-2018)
Figure Global cAMP Functional Assays Revenue and Growth Rate (2017-2018)
Figure Global Internalization Assays Revenue and Growth Rate (2017-2018)
Figure Global Calcium Functional Assays Revenue and Growth Rate (2017-2018)
Figure Global Radioligand Binding & GTPγS Functional Assays Revenue and Growth Rate (2017-2018)
Figure Global β-Arrestin Functional Assays Revenue and Growth Rate (2017-2018)
Figure Global Other Assays Revenue and Growth Rate (2017-2018)
Table Global G-Protein Coupled Receptors (GPCRs) Revenue and Revenue Share by Application (2017-2018)
Figure Global Respiratory Research Revenue and Growth Rate (2017-2018)
Figure Global Cancer Research Revenue and Growth Rate (2017-2018)
Figure Global Inflammation Research Revenue and Growth Rate (2017-2018)
Figure Global CNS Research Revenue and Growth Rate (2017-2018)
Figure Global Cardiovascular Research Revenue and Growth Rate (2017-2018)
Figure Global Metabolic Research Revenue and Growth Rate (2017-2018)
Figure Global Other Applications Revenue and Growth Rate (2017-2018)
Table Global G-Protein Coupled Receptors (GPCRs) Revenue by Regions (2017-2018)
Figure North America G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure North America G-Protein Coupled Receptors (GPCRs) Revenue and Growth Rate (2017-2018)
Figure North America G-Protein Coupled Receptors (GPCRs) by Countries (2017-2018)
Figure North America G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) by Countries (2017-2018)
Figure United States G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure United States G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Canada G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Mexico G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Europe G-Protein Coupled Receptors (GPCRs) Revenue and Growth Rate (2017-2018)
Figure Europe G-Protein Coupled Receptors (GPCRs) by Countries (2017-2018)
Figure Europe G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) by Countries (2017-2018)
Figure Germany G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Germany G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure France G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure UK G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Russia G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Italy G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Rest of Europe G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Asia-Pacific G-Protein Coupled Receptors (GPCRs) Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific G-Protein Coupled Receptors (GPCRs) by Countries (2017-2018)
Figure Asia-Pacific G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) by Countries (2017-2018)
Figure China G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure China G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Japan G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Korea G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure India G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Southeast Asia G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Rest of Asia-Pacific G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure South America G-Protein Coupled Receptors (GPCRs) Revenue and Growth Rate (2017-2018)
Figure South America G-Protein Coupled Receptors (GPCRs) by Countries (2017-2018)
Figure South America G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) by Countries (2017-2018)
Figure Brazil G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Brazil G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Argentina G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Columbia G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Rest of South America G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Middle East and Africa G-Protein Coupled Receptors (GPCRs) Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa G-Protein Coupled Receptors (GPCRs) by Countries (2017-2018)
Figure Middle East and Africa G-Protein Coupled Receptors (GPCRs) Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Saudi Arabia G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure United Arab Emirates G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Egypt G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Nigeria G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure South Africa G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Turkey G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa G-Protein Coupled Receptors (GPCRs) Growth Rate (2017-2018)
Figure Rest of Middle East and Africa G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2017-2018)
Table Becton-Dickinson and Company G-Protein Coupled Receptors (GPCRs) Financial Overview
Table Thermo Fisher Scientific, Inc. G-Protein Coupled Receptors (GPCRs) Financial Overview
Table Merck KGaA G-Protein Coupled Receptors (GPCRs) Financial Overview
Table Eurofins Scientific G-Protein Coupled Receptors (GPCRs) Financial Overview
Table Enzo Biochem Inc. G-Protein Coupled Receptors (GPCRs) Financial Overview
Table QIAGEN G-Protein Coupled Receptors (GPCRs) Financial Overview
Table Perkin Elmer Inc.(Cisbio Bioassays) G-Protein Coupled Receptors (GPCRs) Financial Overview
Table WuXi AppTec(HD Biosciences Co. Ltd) G-Protein Coupled Receptors (GPCRs) Financial Overview
Table Abcam plc G-Protein Coupled Receptors (GPCRs) Financial Overview
Table Promega Corporation G-Protein Coupled Receptors (GPCRs) Financial Overview
Figure Global G-Protein Coupled Receptors (GPCRs) Revenue (Millions USD) and Growth Rate (2018-2025)
Table G-Protein Coupled Receptors (GPCRs) Market Forecast by Regions (2018-2025)
Figure North America G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure United States G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Canada G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Mexico G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Europe G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Germany G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure France G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure UK G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Russia G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Italy G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Rest of Europe G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Asia-Pacific G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure China G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Japan G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Korea G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure India G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Southeast Asia G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Rest of Asia-Pacific G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure South America G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Brazil G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Argentina G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Columbia G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Rest of South America G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Middle East and Africa G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Saudi Arabia G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure United Arab Emirates G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Egypt G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Nigeria G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure South Africa G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Turkey G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Rest of Middle East and Africa G-Protein Coupled Receptors (GPCRs) Market Forecast (2018-2025)
Figure Global G-Protein Coupled Receptors (GPCRs) Forecast by Product (2018-2025)
Figure Global G-Protein Coupled Receptors (GPCRs) Market Share Forecast by Product (2018-2025)
Figure Global G-Protein Coupled Receptors (GPCRs) Forecast by Product (2018-2025)
Figure Global G-Protein Coupled Receptors (GPCRs) Forecast by Assay Type (2018-2025)
Figure Global G-Protein Coupled Receptors (GPCRs) Market Share Forecast by Assay Type (2018-2025)
Figure Global G-Protein Coupled Receptors (GPCRs) Forecast by Assay Type (2018-2025)
Figure Global G-Protein Coupled Receptors (GPCRs) Forecast by Application (2018-2025)
Figure Global G-Protein Coupled Receptors (GPCRs) Market Share Forecast by Application (2018-2025)
Figure Global G-Protein Coupled Receptors (GPCRs) Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|